Gene dosage effects in hereditary peripheral neuropathy: Expression of peripheral myelin protein 22 in Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies nerve biopsies

Neurology

Volumn 49, Issue 6, 1997, Pages 1635-1640

  Gabriel, Jean Marc ^c   Erne, Beat ^c   Pareyson, Davide ^a   Sghirlanzoni, Angelo ^a   Taroni, Franco ^a   Steck, Andreas J ^b  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN PROTEIN;

ARTICLE; GENE DOSAGE; GENE THERAPY; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUMAN TISSUE; NERVE BIOPSY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME;

EID: 0031471867     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.49.6.1635     Document Type: Article

References (22)

1. Suter U, Snipes GJ. Biology and genetics of hereditary motor and sensory neuropathies. Annu Rev Neurosci 1995;18:45-75.
2. Lupski JR, de Oca Luna RM, Slaugenhaupt S, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991;66:219-232.
3. Suter U, Patel PI. Genetic basis of inherited peripheral neuropathies. Hum Mutat 1994;3:95-102.
4. Chance PF, Alderson MK, Leppig KA, et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 1993;72:143-151.
5. Pareyson D, Taroni F. Deletion of the PMP22 gene and hereditary neuropathy with liability to pressure palsies. Curr Opin Neurol 1996;9:348-354.
6. Patel PI, Lupski JR. Charcot-Marie-Tooth disease - a new paradigm for the mechanism of inherited disease. Trends Genet 1994;10:128-133.
7. Yoshikawa H, Nishimura T, Nakatsuji Y, et al. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A. Ann Neurol 1994;35:445-450.
8. Hanemann CO, Stoll G, D'Urso D, et al. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies. J Neurosci Res 1994;37:654-659.
9. Hanemann CO, Stoll G, Muller HW. PMP22 expression in CMT1A neuropathy [letter; comment]. Ann Neurol 1995;37: 136.
10. Vallat JM, Sindou P, Preux PM, et al. Ultrastructural PMP22 expression in inherited demyelinating neuropathies. Ann Neurol 1996;39:813-817.
11. Nishimura T, Yoshikawa H, Fujimura H, Sakoda S, Yanagihara T. Accumulation of peripheral myelin protein 22 in onion bulbs and Schwann cells of biopsied nerves from patients with Charcot-Marie-Tooth disease type 1A. Acta Neuropathol (Berl) 1996;92:454-460.
12. Schenone A, Nobbio L, Mandich P, et al. Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies. Neurology 1997; 48:445-449.
13. Gabriel J-M, Erne B, Miescher GC, et al. Selective loss of myelin-associated glycoprotein from myelin correlates with anti-MAG antibody titer in demyelinating paraproteinaemic polyneuropathy. Brain 1996;119:775-787.
14. Mancardi GL, Uccelli A, Bellone E, et al. 17p11.2 Duplication is a common finding in sporadic cases of Charcot-Marie-Tooth type 1. Eur Neurol 1994;34:135-139.
15. Lorenzetti D, Pareyson D, Sghirlanzoni A, et al. A 1.5-Mb deletion in 17p11.2-p12 is frequently observed in Italian families with hereditary neuropathy with liability to pressure palsies. Am J Hum Genet 1995;56:91-98.
16. Pareyson D, Scaioli V, Taroni F, et al. Phenotypic heterogeneity in hereditary neuropathy with liability to pressure palsies associated with chromosome 17p11.2-12 deletion. Neurology 1996;46:1133-1137.
17. Palau F, Lofgren A, De Jonghe P, et al. Origin of the de novo duplication in Charcot-Marie-Tooth disease type 1A: unequal nonsister chromatid exchange during spermatogenesis. Hum Mol Genet 1993;2:2031-2035.
18. 0 and myelin-associated glycoprotein. J Neurochem 1990;54:1569-1575.
19. Pareek S, Suter U, Snipes GJ, Welcher AA, Shooter EM, Murphy RA. Detection and processing of peripheral myelin protein PMP22 in cultured Schwann cells. J Biol Chem 1993;268: 10372-10379.
20. Miller SL, Pleasure D, Herlyn M, et al. Production and characterization of monoclonal antibodies to peripheral and central nervous system myelin. J Neurochem 1984;43:394-400.
21. Sereda M, Griffiths I, Puhlhofer A, et al. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 1996;16:1049-1060.
22. Adlkofer K, Martini R, Aguzzi A, Zielasek J, Toyka KV, Suter U. Hypermyelination and demyelinating peripheral neuropathy in PMP22-deficient mice. Nat Genet 1995;11:274-280.